Clayton, Dubilier & Rice acquires healthcare services company in GBP577m deal
Clayton, Dubilier & Rice has completed the acquisition of Huntsworth, a provider of specialty services that help pharmaceutical and biotech companies commercialise new therapies and support the life cycle of drug innovation for multiple years, from Phase II and Phase III trials to loss of exclusivity. The transaction was valued at



